|
|
Volumn 186, Issue 8, 1997, Pages 1183-1187
|
|
Dendritic cells as adjuvants for immune-mediated resistance to tumors
a
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIGEN;
BETA GALACTOSIDASE;
CD14 ANTIGEN;
CD34 ANTIGEN;
CD8 ANTIGEN;
CD86 ANTIGEN;
CYTOKINE;
DNA;
FAS ANTIGEN;
GRANULOCYTE COLONY STIMULATING FACTOR;
GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;
HLA DR ANTIGEN;
IMMUNOGLOBULIN IDIOTYPE;
INTERLEUKIN 10;
INTERLEUKIN 12;
INTERLEUKIN 2 RECEPTOR;
MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;
MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;
TUMOR ANTIGEN;
TUMOR NECROSIS FACTOR ALPHA;
ANTIGEN PRESENTATION;
CLINICAL TRIAL;
CYTOTOXIC T LYMPHOCYTE;
DENDRITIC CELL;
HUMAN;
IMMUNIZATION;
NONHUMAN;
NOTE;
PRIORITY JOURNAL;
TUMOR;
TUMOR IMMUNITY;
TUMOR RESISTANCE;
ANIMALS;
CELL TRANSPLANTATION;
DENDRITIC CELLS;
HUMANS;
IMMUNITY, NATURAL;
IMMUNOTHERAPY, ADOPTIVE;
NEOPLASMS;
NEOPLASMS, EXPERIMENTAL;
|
|
EID: 0030840111
PISSN: 00221007
EISSN: None
Source Type: Journal
DOI: 10.1084/jem.186.8.1183 Document Type: Note |
|
Times cited : (414)
|
|
References (51)
|
